Citation

Blake JF, Xu R, Bencsik JR, Xiao D, Kallan NC, Schlachter S, Mitchell IS, Spencer KL, Banka AL, Wallace EM, Gloor SL, Martinson M, Woessner RD, Vigers GP, Brandhuber BJ, Liang J, Safina BS, Li J, Zhang B, Chabot C, Do S, Lee L, Oeh J, Sampath D, Lee BB, Lin K, Liederer BM, Skelton NJ.: Discovery and preclinical pharmacology of a selective ATP-competitive Akt inhibitor (GDC-0068) for the treatment of human tumors. J Med Chem, Volume 55 (18), 2012

Authors

Banka AL, Bencsik JR, Blake JF, Brandhuber BJ, Chabot C, Do S, Gloor SL, Kallan NC, Li J, Liang J, Martinson M, Mitchell IS, Safina BS, Schlachter S, Spencer KL, Vigers GP, Wallace EM, Woessner RD, Xiao D, Xu R, Zhang B, Lee BB, Lee L, Liederer BM, Lin K, Oeh J, Sampath D, Skelton NJ.

Journal

J Med Chem

Year

2012

DOI

10.1021/jm301024w

PubMed

22934575

Machine-readable

REST APIRDF